Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.
In GK, Nallagangula A, Choi JS, Tachiki L, Blackburn MJ, Capone S, Bollin KB, Reuben DY, Shirai K, Zhang-Nunes S, Ragab O, Terando A, Hu JC, Lee H, Bhatia S, Chandra S, Lutzky J, Gibney GT.
In GK, et al.
J Immunother Cancer. 2022 May;10(5):e004839. doi: 10.1136/jitc-2022-004839.
J Immunother Cancer. 2022.
PMID: 35545318
Free PMC article.